MedPath

MOLECULIN LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis

Phase 2
Completed
Conditions
Psoriasis
Interventions
Drug: Placebo
First Posted Date
2013-04-08
Last Posted Date
2014-12-24
Lead Sponsor
Moleculin, LLC
Target Recruit Count
21
Registration Number
NCT01826201
Locations
🇺🇸

International Dermatology Research, Inc., Miami, Florida, United States

🇺🇸

Minnesota Clinical Study Center, Fridley, Minnesota, United States

🇺🇸

Academic Dermatology Associates, Albuquerque, New Mexico, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.